spacer
home > ebr > summer 2004 > driving productivity through strategic partnering
PUBLICATIONS
European Biopharmaceutical Review

Driving Productivity through Strategic Partnering

It has been said: "research takes money and generates ideas, innovation takes ideas and generates money". In reality, a pharmaceutical company must be successful at both if it is to continue to create exciting new medicines offering significant improvements to patients' lives. No single company has a monopoly on innovation, so pharmaceutical manufacturers need to continually find ways to complement their strong internal research with creative external alliances. Analysts expect that more than 50 per cent of new drug approvals in 2004 will originate from the biotech sector, highlighting the importance of accessing this source of innovation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Nigel Sheail, Global Head, Strategic Alliances & Acquisitions at Roche Pharma Partnering

Nigel Sheail is Global Head of Strategic Alliances & Acquisitions at Roche Pharma Partnering. He started at Roche as a local Finance Director, setting up the company's operations in China, and later worked as the Global Controller for Research. Nigel, originally trained as a Molecular Biologist and a qualified Chartered Accountant, held several positions at GlaxoSmithKline before joining Roche more than 10 years ago. Nigel's Strategic Alliances & Acquisitions team is responsible for identifying and accessing strategic partnering opportunities. He has been responsible for a broad range of deals from research and technology collaborations through to Phase III product licensing opportunities.

spacer
Nigel Sheail
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement